Experimental overexpression of regucalcin in prostate cancer cells suppresses inter alia PI3K and AKT levels as well as diminishes osteoblast-mediated mineralization and osteoclastogenesis when co-cultured with pre-osteoblastic or -osteoclastic cell lines [122]. Here, PIK3CA is linked to prostate cancer.